NTRS
44
5
ADI
61
4
HOG
38
5
SNA
60
4
HSY
40
2
DD
53
4
VRTX
62
5
HAS
52
3
HPE
46
2
EQT
57
15
STI
45
10
BBY
58
5
NFLX
59
2
AN
50
7
VFC
56
11
AIZ
73
4
HPQ
53
3
MHK
43
4
IVZ
42
2
AMGN
63
3
NTRS
44
5
ADI
61
4
HOG
38
5
SNA
60
4
HSY
40
2
DD
53
4
VRTX
62
5
HAS
52
3
HPE
46
2
EQT
57
15
STI
45
10
BBY
58
5
NFLX
59
2
AN
50
7
VFC
56
11
AIZ
73
4
HPQ
53
3
MHK
43
4
IVZ
42
2
AMGN
63
3
Financhill
Back

Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings

The Next Tech Giant in Your Pocket?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
65

REGN
Regeneron Pharmaceuticals

Last Price:
1,152.97
Seasonality Move:
5.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Chicago Pit Trader Exposes Shocking Trading Advantage:

See How to Target Up to 383% OVERNIGHT

Regeneron Pharmaceuticals Price Quote

$1,152.97
-0.38 (-0.03%)
(Updated: September 16, 2024 at 3:55 PM ET)

Regeneron Pharmaceuticals Key Stats

Buy
65
Regeneron Pharmaceuticals (REGN) is a Buy
Day range:
$1,150.02 - $1,170.58
52-week range:
$769.19 - $1,211.20
Dividend yield:
0%
P/E ratio:
33.17
P/S ratio:
9.78
P/B ratio:
4.51%
Volume:
330K
Avg. volume:
461.3K
1-year change:
39.59%
Market cap:
$127.1B
Revenue:
$13.1B
EPS:
$37.76

How Much Does Regeneron Pharmaceuticals Make?

Is Regeneron Pharmaceuticals Growing As A Company?

Regeneron Pharmaceuticals Stock Price Performance

What Is Regeneron Pharmaceuticals 52-Week High & Low?

Regeneron Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Regeneron Pharmaceuticals?

Is Regeneron Pharmaceuticals Cash Flow Positive?

  • What Is REGN Cash Flow From Operations?
    Cash flow from operations (TTM) is $4.1B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.3B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.8B

Regeneron Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    REGN return on invested capital is 15.43%
  • What Is Regeneron Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 12.99%
  • What Is REGN Return On Equity?
    ROE is a measure of profitability and is 16.61%

Regeneron Pharmaceuticals Earnings Date & Stock Price

Regeneron Pharmaceuticals Competitors

Regeneron Pharmaceuticals Dividend Yield

Regeneron Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 46% 8.83%
Revenue: 12.32% 4.51%

Analyst Recommendations

Buy Recommendations: 12
Hold Recommendations: 5
Sell Recommendations: 1
Price Target: 1,162.19
Upside from Last Price: 0.77%

Major Shareholders

  • How many REGN shares are owned by institutional investors?
    170.4M REGN shares are owned by institutional investors
  • How many REGN shares are owned by insiders?
    2.1M REGN shares are owned by insiders